Insmed
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $93,425 | $90,340 | $75,500 | $83,693 |
Gross Profit | 72,255 | 68,113 | 56,780 | 65,250 |
EBITDA | -196,560 | -275,805 | -132,609 | -161,541 |
EBIT | -199,282 | -278,504 | -135,460 | -164,279 |
Net Income | -220,524 | -300,609 | -157,091 | -186,061 |
Net Change In Cash | 93,425 | 90,340 | 75,500 | 83,693 |
Free Cash Flow | -184,605 | -129,735 | -188,714 | -132,972 |
Cash | 461,451 | 1,246,799 | 595,729 | 482,374 |
Basic Shares | 173,721 | 154,702 | 148,456 | 144,806 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $305,208 | $245,358 | $188,461 | $164,413 |
Gross Profit | 239,635 | 190,232 | 144,309 | 124,541 |
EBITDA | -654,739 | -429,438 | -375,094 | -250,371 |
EBIT | -665,318 | -453,705 | -402,943 | -270,453 |
Net Income | -749,567 | -481,534 | -434,654 | -294,090 |
Net Change In Cash | 305,208 | 245,358 | 188,461 | 164,413 |
Cost of Revenue | 358,250 | 184,959 | 45,327 | |
Free Cash Flow | -549,535 | -410,317 | -370,591 | -226,170 |
Cash | 482,374 | 1,074,036 | 716,782 | 532,756 |
Basic Shares | 140,433 | 123,035 | 112,111 | 97,605 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.27 |
2024-06-30 | -$1.94 |
2024-03-31 | -$1.06 |
2023-12-31 | -$1.28 |
